Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia
NCT ID: NCT04608032
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2020-09-08
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
NCT01988714
Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network
NCT00930150
Specific Cognitive Remediation for Schizophrenia
NCT01607424
Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning
NCT02901015
Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia
NCT04033978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this double-blind (patients, outcomes assessors) controlled randomized trial the investigators compare patients receiving Ecological Cognitive training program for schizophrenia spectrum disorder \[ECo-Sz\] to patients benefiting from recovery-oriented therapy \[ThOR\]. Patients are treated for two months and monitored for four months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz]
To inform the patient about cognitive impairments and their repercussions ; to train the patient in problem-solving skills through exercices ; to implement strategies in daily life. Duration : two month. Frequency : Two one hour individual sessions and one hour of at-home training per week. Modalities : pen and papers exercices (tools, token, cards, maps and chessboard). Modules : Psychoeducation, Attention, Memory, Executive functions, Social cognition and metacognition, Functional impairments
[Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder
The first group will have \[Eco-Sz\] Ecological Cognitive training program for schizophrenia spectrum disorder
[THoR] Recovery-Oriented Therapy
Individual psychotherapy sessions focussing on autonomy in daily life, management of mood disorders' and functional impact, social skills, motivation and the regulation of sleep and daily activities
Recovery-Oriented Therapy
The second group will have \[THoR\] Recovery-Oriented Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
[Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder
The first group will have \[Eco-Sz\] Ecological Cognitive training program for schizophrenia spectrum disorder
Recovery-Oriented Therapy
The second group will have \[THoR\] Recovery-Oriented Therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positive and Negative stable symptoms (no or few positive and negative symptoms)
* Stable and effective minimum dose of medication (antipsychotic) for the last three months
* Cognitive complaint expressed by the patient
* Informed consent form read, initialed and signed
* Understanding of spoken and read French
* Patient registered on the social welfare system
Exclusion Criteria
* Medical history neurological disorder resulting in hospitalization
* Acute episode in the last three month
* Somatic disorders resulting in cognitive impairment
* Engagement in a research protocol either currently or over the last month
* Neuropsychological assessment evaluation during the last six month
* Patients under the protection of a conservator (simple or reinforced)
* Individuals in vulnerable circumstances
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre hospitalier de Ville-Evrard, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Clémence ISAAC
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clémence ISAAC, PHD
Role: PRINCIPAL_INVESTIGATOR
URC EPS Ville Evrard
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ch Ville Evrard
Neuilly-sur-Marne, , France
URC Ville Evrard
Neuilly-sur-Marne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10477M-NARCIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.